Paravalvular leak prediction after transcatheter aortic valve replacement with self-expandable prosthesis based on quantitative aortic calcification analysis by Wiktorowicz, Agata et al.
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2021;11(2):652-664 | http://dx.doi.org/10.21037/qims-20-669
Original Article 
Paravalvular leak prediction after transcatheter aortic valve 
replacement with self-expandable prosthesis based on 
quantitative aortic calcification analysis
Agata Wiktorowicz1, Adrian Wit2, Krzysztof Piotr Malinowski1, Artur Dziewierz1, Lukasz Rzeszutko1, 
Dariusz Dudek1, Pawel Kleczynski3^
1Jagiellonian University Medical College, Faculty of Medicine, Institute of Cardiology, 2nd Department of Cardiology, 30-688, Krakow, Poland; 
2Faculty of Physics and Applied Computer Science, AGH University of Science and Technology, 30-059 Krakow, Poland; 3Jagiellonian University 
Medical College, Faculty of Medicine, Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, 31-202 Krakow, 
Poland
Correspondence to: Pawel Kleczynski, MD, PhD, FESC. Department of Interventional Cardiology, Jagiellonian University Medical College, 80 
Pradnicka St., 31-501 Krakow, Poland. Email: kleczu@interia.pl.
Background: Paravalvular leak (PVL) is one of the most common complications of transcatheter aortic 
valve replacement (TAVR) and affects short- and long-term outcomes. The aim of this study was to identify 
the computed tomography (CT) imaging biomarkers that allow PVL after TAVR to be predicted.
Methods: Patients were included who had severe aortic valve stenosis, had undergone TAVR with a self-
expanding valve, and had undergone a pre-procedural CT scan. Data on baseline characteristics, procedural 
and long-term outcomes were collected retrospectively. We used MATLAB software with a self-developed 
algorithm for CT scan analysis and found parameters that quantified aortic valve calcifications (AVC) in 
detail.
Results: Fifty patients were included. The identified CT-derived parameters included AVC size, volume, 
thickness and density, as well as calcium radial distribution. The volume of the largest calcium block, 
calcium perimeter and calcium size (assessed by Feret’s diameter) showed a strong association with PVL 
occurrence after TAVR (P=0.012, P=0.001 and P=0.045, respectively). The prognostic model showed that a 
10 mm2 increase in the local AVC amount in each valve section was associated with a 9.8% (95% CI: 2–18%; 
P=0.019) increase in the risk of PVL occurrence in the corresponding area after TAVR. ROC analysis 
revealed that the cut-off point of the AVC area was 96.5 mm2 in the polar coordinate system presentation. 
Kaplan-Meier curves showed worse PVL-free survival in patients with more than 96.5 mm2 of calcium area 
(P=0.013; log-rank).
Conclusions: Quantitative AVC assessment for PVL prediction may play an important role in screening 
before TAVR. In future, the use of quantitative AVC assessment as an imaging biomarker in TAVR 
candidates and the creation and extension of an online database containing quantitative AVC parameters may 
help to identify high PVL risk patients.
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aortic valve replacement (TAVR)
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Introduction
The number of transcatheter aortic valve replacement 
(TAVR) procedures in patients with severe aortic valve 
stenosis (AS) is increasing every year, and the indications 
are being constantly extended (1). One of the most common 
complications after TAVR is paravalvular leak (PVL), which 
influences acute and long-term clinical outcomes (2,3). The 
incidence of at least mild PVL after TAVR is estimated 
at ca. 20 to 60% of patients and occurs more frequently 
than in the case of surgical aortic valve replacement (AVR) 
(4,5). During short- and long-term follow-up, previous 
studies have shown that the occurrence of moderate 
to severe PVL increases mortality after TAVR (6,7). 
However, there is no unified method of identifying patients 
with increased PVL risk. Moreover, there is no clear, 
objective statement regarding perioperative management 
or proper valvular prostheses selection, both of which 
make it possible to reduce the postprocedural occurrence 
of PVL. The European Imaging Biomarkers ALLiance 
(EIBALL), which is a subcommittee of the European 
Society of Radiology (ESR), emphasized the important 
role of imaging biomarkers as they are able to quantify 
the extent of morphological characteristics. Also, the 
EIBALL subcommittee indicates the necessity of building 
imaging databases and their use in the prediction of clinical 
outcomes (8).
The purpose of our study was to identify imaging 
biomarkers to predict PVL occurrence after TAVR. We 
focused on a detailed analysis of aortic valve calcifications 
(AVC) in preprocedural multi-slice computed tomography 
(MSCT) of AS patients qualified for TAVR.
Methods
Fifty patients with severe AS (tricuspid aortic valve, aortic 
valve area <1.0 cm2 and mean pressure gradient >40 mmHg) 
who had undergone TAVR with a self-expanding valve 
(Evolut R, Medtronic Inc, USA) were included in the study. 
The valve size selection was based on the CT-derived 
aortic annulus size, together with perimeter according 
to valve sizing charts. Imaging data from preprocedural 
contrast-enhanced CT and postprocedural transthoracic 
echocardiography (TTE) were analyzed. Data on baseline 
characteristics, procedural and long-term outcomes were 
collected. All clinical and imaging data were collected 
and analyzed retrospectively. The study was approved by 
the Ethical Board of the Jagiellonian University Medical 
College, Krakow, Poland (1072.6120.234.2017). The 
study protocol conforms to the ethical guidelines of the 
1975 Declaration of Helsinki with later amendments. 
Written informed consent was obtained from the patient 
for publication of this study and any accompanying images. 
A copy of the written consent is available for review by the 
Editor-in-Chief of this journal.
All contrast-enhanced CT scans were performed using 
a Toshiba scanner (Toshiba Aquilion 64 CT scanner, 
Toshiba, Tokyo, Japan). All acquisitions were performed 
using an institutional standard protocol and reconstruction 
settings. The protocol involved a scan run that consisted of 
the prospective acquisition of contiguous transverse slices 
(0.5 mm × 64 detector row) in a single breath-hold of 6–10 
seconds, triggered at 60–80% of the electrocardiogram 
R-to-R wave interval.
MSCT scans were analyzed twice: (I) by an experienced 
radiologist before TAVR, using the traditional method; 
(II) by two trained corelab analysts blinded to the clinical 
and echocardiographic data, using dedicated software based 
on MATLAB version R2017a (MathWorks, Natick, MA, 
USA) and ImageJ version 1.51 (NIH, USA) with the BoneJ 
plugin version 1.4.2 (9). The limited intraobserver and 
interobserver variability for AVC evaluation was confirmed 
by Intraclass Correlation Coefficient (ICC), which was 0.992 
(95% CI, 0.990–0.995) and 0.991 (95% CI, 0.988–0.993), 
respectively.
Traditional CT parameters measured by radiologist were 
used to validate the quantitative parameters received by our 
dedicated software based on MATLAB.
TTE was performed on a GE Healthcare echocardiograph 
(Vivid E9, GE Healthcare, Chicago, Illinois, USA). A 
trained physician who was blinded to the clinical and 
radiological data analyzed the postprocedural TTE images 
to detect PVL occurrence in 1-, 3-, 6-, and 12-month 
follow-ups, and its severity was classified according to 
the Valve Academic Research Consortium-2 (VARC-2) 
Consensus Recommendation and American Society of 
Echocardiography guidelines for the evaluation of valvular 
regurgitation after percutaneous intervention (10,11). We 
based on the assessment on semi-quantitative methods 
in color doppler echocardiography such as jet number, 
location, direction, and eccentricity and circumferential 
extent.
Clinical follow-up data, including novel medical 
incidents such as pacemaker implantation, were collected 
retrospectively at 1-, 3-, 6-, and 12-month observations.
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CT-derived data processing
All calculations were performed in the Volume-Of-Interest 
(VOI), which is defined as a stack of closed planar polygons 
of CT slices; this is a 3D space which in our case contains 
the calcified aortic valve (between the highest visible point 
of the aortic apparatus and the left ventricle outflow tract). 
For better visualization of calcified aortic leaflets, the 
initial imaging data underwent computational modelling, 
recomputation and rotation into a set of cross-sections 
parallel to the plane of the valve ring and short axis of the 
ascending aorta. The result of computational modelling is 
presented in Figure 1.
The threshold cut-off value for detection of calcifications 
was set individually for each case, but it was typically set in 
the range 391–689 Hounsfield units (HU). This threshold 
was adopted due to the contrast medium attenuation in the 
aortic root. Every calcified mass except for the AVC was 
excluded from the analysis.
The selected VOI was then used to adjust  the 
corresponding planar projection [region-of-interest 
(ROI)] of the aortic valve using the maximum intensity 
of the calcium conglomerates contained in the VOI. 
However, the large variability of calcium distribution 
causes a quantification problem in a single-slice image 
(before processing). To solve this problem and to provide 
better visualization of local AVC distribution, radial AVC 
presentation was implemented. The ROI presentation was 
inscribed in a circular plane with a central point that was 
previously mathematically assigned as the center point 
of the aortic valve. The AVC amount was individually 
calculated from the mass center in 1-degree slices until the 
entire circle had been analyzed. This approach allowed the 
exact local AVC distribution to be presented, both in the 
direct CT image and in the form of a chart. An exemplary 
image is presented in Figure 2, which shows the radial image 
intensity (y-axis) in reference to degree coordination (x-axis).
CT-derived parameters
Technical aspects of CT data acquisition and AVC 
quantification have been described in detail previously 
(12,13). The AVCs were presented and analyzed in a 
twofold manner:
(I) AVC was presented as a whole mass in the stenotic 
valve. In this category, the analyzed parameters 
were assigned to two groups: morphometric 
(AVC size, volume and thickness in ROI and VOI 
presentation) and textural (AVC radiodensity).
(II) AVC was presented in a radial presentation. This 
category presents AVC orientation and distribution 
(topological parameters); the local AVC amount 
was described in each of the three sections of 
the valve. The aortic valve ROI projection was 
presented on the circular plane and was subdivided 
into three zones, each containing 120 1-degree 
slices (Figure 3A). The AVC amount was calculated 
radially from the stenotic valve mass center for each 
1-degree slice, and the total in each of the three 
sections was then calculated. The AVC amount is 
presented in square millimeters (mm2).
The presentation of the AVC amount in each of the 
three valve ROI sections allowed us to compare the local 
Figure 1 The coronal view (A) and perpendicular plane (B) for aortic valve. The images were rotated to obtain planes perpendicular to the 
aortic valve. The yellow dotted squares show the boundaries for VOI and ROI analysis. ROI, region of interest; VOI, volume of interest.
BA
655Quantitative Imaging in Medicine and Surgery, Vol 11, No 2 February 2021
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2021;11(2):652-664 | http://dx.doi.org/10.21037/qims-20-669
AVC amount and the location of the PVL site after TAVR 
(if it occurred) (Figure 3B). Additionally, 3D AVC models 
with a color scale depending on the degree of calcium 
thickness were obtained (Figure 4).
A single case analysis using our method of AVC 
quantification took about 20 minutes.








where CI = cover index (-), Pd = prosthesis diameter (mm), 
Ad = annulus diameter (mm),
Ellipticity and eccentricity indexes were calculated 
in three ways: based on traditional CT measurements; 
based on separate quantitative AVC calculations with ROI 
diameter and Feret’s diameter. The ellipticity index was 
defined as the annulus maximum/minimum diameter. 
The eccentricity index was defined as 1 minus the annulus 
minimal diameter/maximal diameter.
Statistical analysis
Categorical  variables  were expressed as  numbers 
(percentages). Continuous variables were expressed as 
mean ± standard deviation or median (interquartile range). 
Figure 2 Radial presentation of the aortic valve. Visualization of the polar coordinate system makes it possible to present the degree of 
calcification on a single aortic leaflet (A,B,C).
A B CC
Figure 3 Radial calcium presentation: (A) ROI presentation divided into three zones (120 degrees each) and radial summation of AVC 
amount in each zone (explanation in the text); (B) TTE image with PVL location. AVC, aortic valve calcification; PVL, paravalvular leak; 
ROI, region of interest; TTE, transthoracic echocardiography.
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The risk of PVL due to the AVC amount was assessed 
using the Cox method. The best multivariable model was 
chosen using stepwise combined regression with the Akaike 
information criterion as the target, with calcium locked 
in the model and adjusted for gender, body mass index 
and medical history. Risk ratios were presented with 95% 
confidence intervals. In the radial presentation analysis, 
the Cox regression model was constructed using one valve 
section as an observation and additional clustering of 
sections was considered. Bootstrap validation with 1,000 
simulations was performed on the multivariable model 
with C-statistics as a measure of goodness of fit. ROC 
analysis was performed to calculate the cut-off point with 
the most discriminative power, then Kaplan-Meier curves 
with 95% CI were plotted for cases below and above the 
cut-off point, which were then compared using the log-
rank test. To assess the agreement between traditional 
MSCT measurement and AVC quantitative assessment, 
interobserver repeatability calculations were performed 
using Bland-Altman analysis. All tests were 2-tailed, and 
a P value <0.05 was considered statistically significant. 
All statistical analyses were performed using JMP 14.3 
(SAS Institute Inc., Cary, NC, USA, 2019) and R 3.5.3 (R 
Foundation for Statistical Computing, Vienna, Austria, 
2019).
Results
Baseline and follow up data
Table 1 shows the baseline characteristics and baseline 
echocardiographic and CT data (measured using the 
traditional method) of the study population.
During TAVR procedure, three patients required 
balloon postdilatation (6%), which was performed in case 
of PVL 2 or more or in case of prosthesis underexpansion 
as assessed in TTE immediately after valve deployment. 
No periprocedural life-threatening complications (cardiac 
arrest, cardiac tamponade, severe arrhythmias) were 
observed. Five patients required pacemaker implantation 
within a year of their TAVR procedures (10%). In 23 
patients (46%), PVL occurred during long-term follow-
up: 13 patients had PVL grade 1 (26%), 8 patients had PVL 
grade 2 (16%), and 2 patients had PVL grade 3 (4%).
AVC quantitative parameters
Measured using our method, the quantitative AVC 
parameters of the study population are shown in Table 2.
The univariate model shows significant association 
between the volume of the largest calcium block (VOI 
presentation), calcium perimeter and Feret’s diameter (14) 
(ROI presentation), and PVL occurrence after TAVR. 
There was no significant correlation between the remaining 
ROI and VOI AVC parameters and long-term perivalvular 
complications after TAVR (pacemaker implantation and 
PVL occurrence) (Table 3).
Radial presentation-PVL prognostic model and cross-
validation of the results
The multivariable model shows that AVC is an independent 
PVL predictor (Table 4). A 10 mm2 increase in local AVC 
amount in each section was associated with a 9.8% (95% 
Figure 4 Exemplary AVC 3D models with a color scale representing calcium thickness. The brightest color is the thickest AVC part. (A) 
Separated AVC 3D models; (B) 3D models of AVC and its location in the aortic valve. 3D, 3 dimensional; AVC, aortic valve calcification.
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CI: 2%–18%; P=0.019) increase in the risk of PVL after 
TAVR in the corresponding area.
Bootstrap validation with 1,000 simulations was 
performed on the multivariable model with C-statistics as 
a measure of goodness of fit. C-statistics was 0.7, which 
indicates a good model (Bootstrap validation revealed 
C-statistic of 0.6).
ROC analysis revealed a cut-off point of 96.5 mm2 of the 
AVC amount assessed in radial slices. Kaplan-Meier curves 
showed the lowest PVL-free survival in patients with more 
than 96.5 mm2 of calcium (P=0.013; log-rank) (Figure 5). 
Figure 6 shows 3D models and AVC quantification in the 
radial presentation of three exemplary cases. In case 1, the 
AVC amount in each field did not exceed the threshold. In 
Table 1 Baseline characteristics, baseline echocardiographic and 
computed tomography data 
Variable Outcome
Baseline characteristics
Age, median (IQR) (years) 83.0 (79.0–86.0)
Age ≥80 years (%) 71.8
Women (%) 71.8
BMI, median (IQR) (kg/m2) 26.8 (24.8–29.0)
PCI before TAVR (%) 64.1
CABG before TAVR (%) 15.4
DM (%) 33.3
DM on insulin (%) 10.3
Arterial hypertension (%) 92.3
Hyperlipidemia (%) 56.4
CKD (%) 25.6
Baseline echocardiographic and CT* data
Mean AVA, median (IQR) (cm2) 0.6 (0.6–0.8)
Mean PG max, median (IQR) (mmHg) 75.0 (56.0–98.0)
Mean PG mean, median (IQR) (mmHg) 47.0 (33.0–61.0)
Mean EF, median (IQR) (%) 60.0 (40.0–65.0)
Minimal valve annulus diameter in CT, 
median (IQR) (mm)
23.0 (21.0–25.0)
Maximal valve annulus diameter in CT, 
median (IQR) (mm)
28.0 (26.5–31.0)
Mean cover index (%) 11.55±6.54 
*, CT data based on traditional measurements. BMI, body mass 
index; PCI, percutaneous coronary intervention; CABG, coronary 
artery bypass; TAVR, transcatheter aortic valve replacement; 
DM, diabetes mellitus; CKD, chronic kidney disease; AVA, aortic 
valve area; PG, pressure gradient; EF, ejection fraction; CT, 
computed tomography.
Table 2 Aortic valve calcification quantitative parameters 
Variable Outcome
Morfometric AVC parameters
The volume of interest (VOI)*
Calcium volume, median  
(IQR) (mm3)
613.3 (345.3–1184.8)
Mean calcium thickness, median 
(IQR) (mm)
3.0 (2.8–3.6)
Maximal calcium thickness, 
median (IQR) (mm)
4.6 (4.0–5.6)
Number of separate calcium 
blocks, median (IQR) (-)
4.0 (3.0–6.0)
The largest calcium block 
volume, median (IQR) (mm3)
334.0 (197.9–729.8)
The region of interest (ROI)**
ROI area, median (IQR) (mm2) 826.6 (695.0–1041.4)
ROI perimeter, median  
(IQR) (mm)
114.3 (103.5–129.5)
Calcium area, median  
(IQR) (mm2)
267.3 (148.5–324.3)
Calcium perimeter, median  
(IQR) (mm)
168.8 (140.2–202.1)
Maximal Feret diameter, median 
(IQR) (mm)
36.8 (33.7–42.3)




Minimal calcium radiodensity, 
median (IQR) (HU)
534.0 (454.0–592.0)
Maximal calcium radiodensity, 
median (IQR) (HU)
1370.0 (1280.0–1506.0)




Field A, median (IQR) (mm2) 64.9 (35.4–111.3)
Field B, median (IQR) (mm2) 78.4 (40.6–123.4)
Field C, median (IQR) (mm2) 104.4 (79.0–133.1)
*, refers to AVC volumetric parameters; **, refers to planar AVC 
projection (2D image). HU, Hounsfield units.
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this case, PVL formation was not observed at the 12-month 
follow-up. In cases 2 and 3, the AVC amount exceeded the 
threshold in field C in case 2, and in fields B and C in case 3. 
In these cases, PVL was observed at the 6-month TTE 
follow-up in locations corresponding to these fields in CT.
Additionally, we assessed the agreement between 
traditional CT measurement and AVC quantitative 
assessment of ellipticity and eccentricity indexes based on 
ROI diameter and Feret’s diameter (Table 5 and Figure 7). 
Figure 8 shows Bland-Altman plots for comparison of 
traditional CT measurements and AVC quantitative 
assessment. For ellipticity index assessment, the mean 
relative differences were −2.99% (−6.93–0.96%) and 
−0.50% (−4.28–3.28%), respectively. For the eccentricity 
index, the mean relative differences were −16.11% (−31.08% 
to −1.14%) and −4.64% (−18.43% to 9.14%), respectively.
Discussion
Preoperative CT assessment of patients with severe AS 
who have qualified for TAVR is obligatory and enables 
accurate procedure planning and correct device selection. 
Table 3 Univariate analysis of the impact of aortic valve calcifications characteristics on paravalvular leak occurrence after transcatheter aortic 
valve replacement
Variable Odds ratio LCI UCI P value
The volume of interest (VOI)*
Calcium volume (mm3) 1.0000 1.0000 1.0000 0.19
Mean calcium thickness (mm) 1.1632 0.4701 2.8779 0.74
Maximal calcium thickness (mm) 1.0909 0.6844 1.7389 0.71
Number of separate calcium blocks (-) 1.1536 0.9698 1.3721 0.11
The largest calcium block volume (mm3) 1.0009 1.0002 1.0016 0.012
The region of interest (ROI)**
Feret’s diameter (mm) 1.1292 1.0569 1.2065 0.001
Calcium area (mm2) 1.0025 0.9993 1.0057 0.12
Calcium perimeter (mm) 1.0046 1.0001 1.0091 0.045
Mean calcium density (HU) 1.0012 0.9973 1.0052 0.55
Maximal calcium density (HU) 1.0014 0.9986 1.0041 0.34
Minimal calcium density (HU) 1.0008 0.9960 1.0056 0.74
*, refers to AVC volumetric parameters; **, refers to planar AVC projection (2D image). HU, Hounsfield units; mm, millimeters; mm2, square 
millimeters; mm3, cubic millimeters.
Table 4 Multivariable model for local paravalvular leak occurrence in radial presentation
Variable Exp (coef) Exp (-coef) Lower 95% Upper 95% P value
AVC per 10 mm2 1.1613 0.8611 1.0447 1.291 0.006
Balloon predilatation 0.3663 2.7302 0.1282 1.047 0.06
Age per 1 year 0.9425 1.0611 0.8990 0.988 0.014
BMI per 1 kg/m2 1.0266 0.9741 0.8591 1.227 0.77
DM 0.6994 1.4297 0.2086 2.345 0.56
PCI before TAVR 0.9904 1.0097 0.3135 3.129 0.99
AVC, aortic valve calcifications; BMI, body mass index; DM, diabetes mellitus; PCI, percutaneous coronary intervention; TAVR, 
transcatheter aortic valve replacement.
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CT assessment makes it possible to reduce the number of 
postoperative complications such as the occurrence of PVL 
(15-20). Severe AVC is one of the factors that makes PVL 
more likely after TAVR, which is why it is obligatory to 
assess AVC degree in CT (21-23).
Pre-TAVR AVC assessment in CT is based on a semi-
quantitative method (Agatston score) or subjective visual 
assessment of CT data. For now, there is no prognostic 
model and no consensus on a specific imaging biomarker 
that would allow for unambiguous, objective identification 
of patients with a high risk of PVL. The authors of only 
a few previous studies have attempted to establish an 
objective, quantitative methodology of AVC description 
(24,25). Single reports have indicated the role of AVC 
distribution in local PVL formation (26,27). On the other 
hand, these reports show a lack of a harmonized, objective 
AVC assessment method.
We present a unique method of objective AVC 
assessment and its usefulness in patients who have qualified 
for TAVR. By building a database of quantitative AVC 
parameters, we specify parameters that allow estimation 
of high PVL formation after TAVR (largest calcium block 
volume, calcium perimeter, Feret’s diameter). Additionally, 
radial presentation makes it possible to identify the exact 
location of higher probability of PVL occurrence in relation 
to the valve ring.
Initial assessment shows that our method has very good 
agreement with traditional CT measurements. Additionally, 
Figure 5 Kaplan-Meier curves for PVL occurrence during long-
term follow-up, stratified by AVC (radial presentation). Blue: 
AVC amount <96.5 mm2; red: AVC amount ≥96.5 mm2; dashed 
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Time to PVL (days)
Figure 6 3D models and AVC quantification in three cases (explanation in the text). 3D, 3-dimensional; AVC, aortic valve calcification.
A: 31.17 mm2 
B: 47.88 mm2
C: 67.62 mm2
A: 20.92 mm2 
B: 40.56 mm2
C: 154.62 mm2
A: 71.94 mm2 
B: 121.82 mm2
C: 125.59 mm2
Case 1 Case 2 Case 3
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a single case analysis is quick, thus it is possible to 
implement our method in real-time assessment. The 
predictive model for PVL occurrence based on imaging and 
clinical data is cross validated.
In the future, our work may affect diagnostic and 
therapeutic pathways in patients qualified for TAVR. 
Firstly, based on mathematical data, we will be able to list 
a group of patients with an increased likelihood of PVL 
formation. This group of patients will require increased 
observation both in the perioperative period and in long-
term follow-ups. The first difference in the rate of PVL 
formation between patients with an AVC amount below 
and above 96.5 mm2 was noticed after just 1 month of 
follow-up. This could be very important information for 
physicians to do the first TTE within one month of TAVR 
for patients with higher AVC. Secondly, localization of 
the problematic area of the valve may have an impact on 
valve prosthesis selection. Additionally, the combination of 
radial presentation data with the more frequently described 
personalized simulations of the TAVR procedure (28-31) 
may affect both device selection and design.
Considering the increase in the popularity of TAVR, 
the relatively high PVL occurrence after TAVR, and the 
increase in mortality in patients with moderate to severe 
PVL, careful assessment of PVL predictors is required. In 
the future, the use of quantitative AVC parameters as PVL 
imaging biomarkers in TAVR patients may help to identify 
high PVL risk patients and may have an impact on device 
design and selection. These may impact the planning of 
the therapeutic and control path before and after TAVR in 
high PVL risk patients. To achieve these goals, the creation 
and extension of an online database containing quantitative 
AVC parameters is needed.
Study limitations
The main limitation of our study is the relatively small 
sample size and the lack of postprocedural PVL evaluation 
Figure 7 The AVC measurements using the traditional method (A) and the Feret’s method (B). In the standard approach (A), the maximum 
and minimum ROI diameter are determined based on the individual judgment of the analyst, as the diameters of the most fitted circle. In 
the Feret’s method (B), results are selected from maximal and minimal length of the rectangle fitted in different angles. This method ensures 
the repeatability and the high accuracy. AVC, aortic valve calcifications; ROI, region of interest.
Table 5 Mean ellipticity and eccentricity indexes measured in traditional computed tomography assessment and aortic valve calcifications 




AVC quantitative assessment in software based of MATLAB
Maximal and minimal 
diameters measured in ROI
Maximal and minimal diameter expressed 
as maximal and minimal Feret’s diameter
Mean ellipticity index (95% CI) 1.23 (1.20–1.26) 1.19 (1.15–1.23) 1.22 (1.18–1.26)
Mean eccentricity index (95% CI) 0.18 (0.16–0.20) 0.15 (0.12–0.18) 0.17 (0.15–0.20)
AVC, aortic valve calcifications; CT, computed tomography; ROI, region of interest.
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in transesophageal echocardiography, which is a reference 
method. Another limitation is the lack of the exact date 
of PVL formation as the patients were followed up on 
prescheduled dates on which only the PVL was revealed.
Most of the literature data regarding aortic valve calcium 
score refer to measurements based on non-contrast CT 
scans, which should be the reference method for AVC 
assessment. The quality of contrast enhanced CTs results 
from the interaction of multiple variables related to patient, 
scanner and contrast medium. Unlike non-contrast scans, 
the threshold for calcium detection on contrast-enhanced 
CT scans has not been standardized in the published 
reports. Both fixed-intensity values as well as dynamic 
thresholds related to luminal attenuation in the ascending 
aorta have been suggested (32). In our study, the threshold 
cut-off value was set individually (391–689 HU) for each 
case and was adopted due to contrast medium attenuation 
in the aortic root. Aortic valvular calcium score assessment 
based on contrast-enhanced CT is not a recommended 
method, but we chose to perform our measurements on 
these data because of their prevalence in TAVR patients. 
Contrast-enhanced CT is performed during preoperative 
assessment of every TAVR patient, and the use of this data 
for AVC evaluation carries no risk of additional radiation 
for these patients. Additionally, some studies have shown 
that AVC assessment in contrast-enhanced CT has good 
agreement with non-contrast MSCT (33).
Conclusions
Detailed, quantitative AVC assessment for PVL prediction 
may play an important role in screening before TAVR. 
In future, the use of quantitative AVC assessment as an 
imaging biomarker in TAVR candidates and the creation 
Figure 8 Bland-Altman plots for ellipticity index (A,B) and eccentricity index (C,D). AVC ellipticity and eccentricity indexes calculated 
on the basis of ROI maximal and minimal diameter; CT ellipticity and eccentricity indexes calculated on the basis of traditional CT 
measurements; Feret’s diameter – ellipticity/eccentricity indexes calculated on the basis of ROI and Feret’s minimal and maximal diameter. 
AVC, aortic valve calcification; CT, computed tomography; ROI, region of interest.
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and extension of an online database containing quantitative 
AVC parameters may help to identify high PVL risk 
patients and may affect the therapeutic and diagnostic 
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